Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I use the one through this site
I was in a stock (mjpi) last year it shot from .40 to 8.00 in a couple months... then the bottom fell out and it’s like.02
I definitely don’t think this is a pump and dump company like that one was but these huge gains make me second guess myself..
Anything can happen, I believe a realistic target for July-18 is $2.50 to $3.50 to would give Inmed a market cap of roughly $370 o $518 million. It could easily be double or triple that with positive ph1 results, news on the commercialization of the biosynthesis or both.
Great to share for sure!! I feel the same way, I tell everyone that will listen (coworkers,family,friends) I find the most look at me like either they don’t care or don’t get it...
Anyone else get their packet in the mail from inmed today?
Not today my friend pretty big resistance at .73 & .77
It’s still trading In the us market
Glad I add another 1,000 shares at 2.69
That’s not true I sold at .64 and rebought at .52 adding an additional 7,000 shares for free.
I’m definitely long term on this one this will be a monster... that being said adding more shares for free will only make more more in the long run.
The “classic” pump and dump... would that involve insiders “dumping” their shares as the price goes up? What insiders have sold?
Hands down Inmed will be a multi Billion dollar company. It will not happen overnight. Once they have the commercial scale complete of the biosynthesis system and are supplying other companies that alone will be worth Billions.
Someone bought 100k shares @.67 @1122!!
Pretty good article... if inmed can get their biosynthesis program commercialized They will rule this part of the sector
http://www.baystreet.ca/articles/marketwatch.aspx?id=814
Thoughts on the insider sell off?
Shares Sold
Total Sale Price
Terry Booth
Chief Executive Officer of Aurora
November 28, 2017 $7.94 700,000 $5,558,000
Jose Del Moral
Director of Aurora
November 28, 2017 $8.48 500,000 $4,240,000
Stephen Dobler
President of Aurora
November 28, 2017 $8.23 900,000 $7,407,000
Ronan Levy
Vice President of Business and Corporate Affairs of Aurora
November 28, 2017 $8.49 71,670 $608,478
TOTAL 2,171,670 $17,813,478
never really thought of that but that makes sense. Im game, I will set my limit at $200 a share tomorrow because honestly boys if I was offered that priced i'd sell
Something to think about....
Currently:
Gwph - league of their own
Zyne
Cara
Insy
All roughly in the Same category which one has a drug on the market...that’s right none!!
Imlff - at the bottom
With inmeds current share structure they’re priced roughly 5-6x’s less then the 3 stocks above.
Once we get through phase 1 we should be @ $2.75 - $3.30 and that price doesn’t include the a valuation for biosynthesis.
Just my opinion on where we stand and are headed. GLTA
Anyone notice the post market change of .03? I have yet to see any trading pre or post market in the past year...
You’re right Ricky baby!! We have a rough idea that will be in 2018 but who knows when.
Yea 96000 will be plenty here!! I feel like it will drop back into the .40’s but I don’t have the balls to sit out and wait for it hahaha. I don’t want to miss the real news on the biosynthesis program that sends this into the dollars.
I got out at .65 and back in at .54 solely to add additional shares. I got 1000’s more at no additional cost (excluding trading fees) pretty psyched!!
Look at standard 4 on page 6 I think that’s very doable
https://listingcenter.nasdaq.com/assets/initialguide.pdf
Anyone else get they notice for the annual shareholders meeting and vote? We must vote by December 13th vote is the 14th
It ran to .72 when the inmed article was run in Forbes magazine
We will be over $4 a share next fall... we will have the first round of clinicals done and scaled the biosynthesis to commercial level. 2019 we’ll be on the nasdaq and from there boys, we’ll all be wealthy!
The medical aspect of the mj sector has nothing to worry about wether the us legalizes mj or not...
Heroin is illegal for recreational use...
Opioid medication is not...
The are both categorized the same from a narcotic standpoint.
IMO they only way inmed sells out is if they are extremely overvalued like (20billion) or they have absolutely nothing...
My reply was toward the ernie and radly type posts not yours... I like you and many others have been watching the board for a long time and it seems like after the forbes article it drew interest but people were expecting it to just blow up from April on with no news...
I totally agree I definitely think it's time to see some progress. I tend to think that won't happen until the company proves through the trials they have the "holy grail" system. As it stands now there's good information on some test but nothing that shows they can take a disease and match it with cannabinoids and actually provide a treatment.
That being said I don't believe they put this management team with their record and reputation in place with hocus pocus.
I don't understand how so many people expect this stock to be a $4.00 stock with no clinical trials or any income from their bioinformatics program...
This is a long term hold 2018 and 2019 will big years for this company.
What does that mean, good or bad?
We just need the "news" you speak of hahaha. I'm feeling like the next big run will be when they start selling the bioinformatics info showing they're generating revenue in the 3rd/4th quarter... and again as they get positive results from (EB). until then is the time to buy!!! IMHO